BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 29926183)

  • 1. Comparative clinicopathological and cytomorphological analyses of peritoneal carcinomatosis associated with metastatic breast carcinoma and primary peritoneal/ovarian carcinoma in patients with a history of breast carcinoma.
    Na K; Lee JY; Sung JY; Kim GM; Koo JS; Kim HS
    Virchows Arch; 2018 Aug; 473(2):165-175. PubMed ID: 29926183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A diagnostic dilemma following risk-reducing surgery for BRCA1 mutation - a case report of primary papillary serous carcinoma presenting as sigmoid cancer.
    Chand M; Moore PJ; Clarke AD; Nash GF; Hickisk T
    World J Surg Oncol; 2007 Sep; 5():102. PubMed ID: 17850658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic factors value of germline and somatic brca in patients undergoing surgery for recurrent ovarian cancer with liver metastases.
    Gallotta V; Conte C; D'Indinosante M; Capoluongo E; Minucci A; De Rose AM; Ardito F; Giuliante F; Di Giorgio A; Zannoni GF; Fagotti A; Margreiter C; Scambia G; Ferrandina G
    Eur J Surg Oncol; 2019 Nov; 45(11):2096-2102. PubMed ID: 31227342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abdominal carcinomatosis in women with a history of breast cancer.
    Garg R; Zahurak ML; Trimble EL; Armstrong DK; Bristow RE
    Gynecol Oncol; 2005 Oct; 99(1):65-70. PubMed ID: 15979132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PAX8 Expression in a Subset of Malignant Peritoneal Mesotheliomas and Benign Mesothelium has Diagnostic Implications in the Differential Diagnosis of Ovarian Serous Carcinoma.
    Chapel DB; Husain AN; Krausz T; McGregor SM
    Am J Surg Pathol; 2017 Dec; 41(12):1675-1682. PubMed ID: 28877056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BRCA mutational status, initial disease presentation, and clinical outcome in high-grade serous advanced ovarian cancer: a multicenter study.
    Petrillo M; Marchetti C; De Leo R; Musella A; Capoluongo E; Paris I; Benedetti Panici P; Scambia G; Fagotti A
    Am J Obstet Gynecol; 2017 Sep; 217(3):334.e1-334.e9. PubMed ID: 28549976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary Peritoneal High-grade Serous Carcinoma Misinterpreted as Metastatic Breast Carcinoma: A Rare Encounter in Peritoneal Fluid Cytology.
    Park S; Cho EY; Oh YL; Park YH; Kim HS
    Anticancer Res; 2020 May; 40(5):2933-2939. PubMed ID: 32366445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BRCA1 and BRCA2 mutations in males with familial breast and ovarian cancer syndrome. Results of a Spanish multicenter study.
    de Juan I; Palanca S; Domenech A; Feliubadaló L; Segura Á; Osorio A; Chirivella I; de la Hoya M; Sánchez AB; Infante M; Tena I; Díez O; Garcia-Casado Z; Vega A; Teulé À; Barroso A; Pérez P; Durán M; Carrasco E; Juan-Fita MJ; Murria R; Llop M; Barragan E; Izquierdo Á; Benítez J; Caldés T; Salas D; Bolufer P
    Fam Cancer; 2015 Dec; 14(4):505-13. PubMed ID: 26026974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The lack of clinical value of peritoneal washing cytology in high risk patients undergoing risk-reducing salpingo-oophorectomy: a retrospective study and review.
    Blok F; Roes EM; van Leenders GJ; van Beekhuizen HJ
    BMC Cancer; 2016 Jan; 16():18. PubMed ID: 26768420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of ascitic fluid cell block for diagnosing primary ovarian, peritoneal, and tubal cancer in patients with peritoneal carcinomatosis with ascites.
    Uehara T; Yoshida H; Fukuhara M; Yoshida M; Motoi N; Sugawara S; Sone M; Arai Y; Tamura K; Uno M; Ishikawa M; Kato T
    Gynecol Oncol; 2020 May; 157(2):398-404. PubMed ID: 32063274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peritoneal cancer arising after total abdominal hysterectomy and bilateral salpingo-oophorectomy for cervical cancer in a patient with right breast cancer and germline mutation of BRCA1 gene: a case report and literature review.
    Harao M; Ando J; Kamata H; Hoshi N; Igarashi S; Sekiguchi R; Sugano K
    Breast Cancer; 2018 Mar; 25(2):243-249. PubMed ID: 29094253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Routine second-look after surgical treatment of colonic peritoneal carcinomatosis.
    Delhorme JB; Triki E; Romain B; Meyer N; Rohr S; Brigand C
    J Visc Surg; 2015 Jun; 152(3):149-54. PubMed ID: 25650364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peritoneal carcinoma in women with genetic susceptibility: implications for Jewish populations.
    Casey MJ; Bewtra C
    Fam Cancer; 2004; 3(3-4):265-81. PubMed ID: 15516851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of peritoneal carcinomatosis from ovarian cancer by surgical cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC).
    Robella M; Vaira M; Marsanic P; Mellano A; Borsano A; Cinquegrana A; Sottile A; De Simone M
    Minerva Chir; 2014 Feb; 69(1):27-35. PubMed ID: 24675244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. False-negative peritoneal cytology in metastatic ovarian carcinoma.
    Pretorius RG; Lee KR; Papillo J; Baker S; Belinson J
    Obstet Gynecol; 1986 Nov; 68(5):619-23. PubMed ID: 3763072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytological Findings of Ascitic Fluid with a Malignant Ovarian Steroid Cell Tumor: A Case Report and Literature Review.
    Kosaka N; Hasegawa K; Kiuchi K; Ochiai S; Nagai T; Machida H; Imai Y; Fukasawa I
    Acta Cytol; 2017; 61(2):165-171. PubMed ID: 28343229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary and metastatic ovarian cancer in patients with prior breast carcinoma. Pre-operative markers and treatment results.
    Tserkezoglou A; Kontou S; Hadjieleftheriou G; Apostolikas N; Vassilomanolakis M; Sikiotis K; Salamalekis E; Tseke P; Magiakos G
    Anticancer Res; 2006; 26(3B):2339-44. PubMed ID: 16821613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peritoneal lavage cytology: an assessment of its value during prophylactic oophorectomy.
    Colgan TJ; Boerner SL; Murphy J; Cole DE; Narod S; Rosen B
    Gynecol Oncol; 2002 Jun; 85(3):397-403. PubMed ID: 12051865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peritonectomy procedures and HIPEC in the treatment of peritoneal carcinomatosis from ovarian cancer: Long-term outcomes and perspectives from a high-volume center.
    Muñoz-Casares FC; Medina-Fernández FJ; Arjona-Sánchez Á; Casado-Adam Á; Sánchez-Hidalgo JM; Rubio MJ; Ortega-Salas R; Muñoz-Villanueva MC; Rufián-Peña S; Briceño FJ
    Eur J Surg Oncol; 2016 Feb; 42(2):224-33. PubMed ID: 26673283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intra-abdominal carcinomatosis after prophylactic oophorectomy in women of hereditary breast ovarian cancer syndrome kindreds associated with BRCA1 and BRCA2 mutations.
    Casey MJ; Synder C; Bewtra C; Narod SA; Watson P; Lynch HT
    Gynecol Oncol; 2005 May; 97(2):457-67. PubMed ID: 15863145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.